title: c-Fos immunoreactivity of neural cells in intoxication due to high-dose methamphetamine.
abstract: Methamphetamine (METH) is a powerful and toxic psychostimulant that is abused worldwide. Although many studies of its toxic functions have been done on animals and humans, the mechanism is still poorly understood. In addition, the doses of METH examined have often been low. Here, we investigated the effects of intoxication due to administration of 20 mg/kg METH on neuronal activity. The mice showed hyperthermia and stereotyped behavior during 60 min after injection. We examined plasma stress hormone levels, which indicated that exposure to METH stimulated the hypothalamic-pituitary-adrenal (HPA) axis and caused release of stress hormones soon after injection. The maximum levels of adrenocorticotropic hormone and corticosterone occurred 10 and 60 min, respectively, after injection. We examined c-Fos protein in 16 different brain regions at 60 min post injection to identify potential brain regions subject to the stimulant effect. Nine regions, including the anterior hypothalamic area, medial preoptic area, lateral hypothalamic area, paraventricular thalamic nucleus, lateral anterior hypothalamic nucleus, lateral septum, striatum, nucleus accumbens, and amygdala, showed a significant increase in c-Fos expression, while the other seven regions did not. These results indicate that responsive neurons in the regions containing c-Fos immunoreactivity (Fos-IR) may undergo cellular reaction to high-dose METH administration. The present study provides support for a relationship among hyperthermia, the HPA axis and neuronal activities in limited brain regions on exposure to 20 mg/kg METH.
authors.affiliation: Department of Medical Toxicology, Kawasaki Medical School.
authors.forename: Masafumi
authors.initials: M
authors.lastname: Tomita
authors.forename: Hironobu
authors.initials: H
authors.lastname: Katsuyama
authors.forename: Yoko
authors.initials: Y
authors.lastname: Watanabe
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Shibaike
authors.forename: Haruhiko
authors.initials: H
authors.lastname: Yoshinari
authors.forename: Jia Wei
authors.initials: JW
authors.lastname: Tee
authors.forename: Nobuhisa
authors.initials: N
authors.lastname: Iwachidou
authors.forename: Osamu
authors.initials: O
authors.lastname: Miyamoto
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D005334:Fever / Q000139:chemically induced; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects / Q000378:metabolism; D007150:Immunohistochemistry; D007274:Injections, Intraperitoneal; D008297:Male; D008694:Methamphetamine / Q000008:administration & dosage / Q000009:adverse effects* / Q000506:poisoning*; D051379:Mice; D008810:Mice, Inbred C57BL; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism* / Q000502:physiology; D010913:Pituitary-Adrenal System / Q000187:drug effects / Q000378:metabolism; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism*
chemical_list: D016760:Proto-Oncogene Proteins c-fos; D008694:Methamphetamine; D000324:Adrenocorticotropic Hormone